Innate Pharma Beheer
Beheer criteriumcontroles 4/4
De CEO Innate Pharma's is Herve Brailly, benoemd in Jan1999, heeft een ambtstermijn van 25.75 jaar. bezit rechtstreeks 0.91% van de aandelen van het bedrijf, ter waarde € 1.48M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 4.6 jaar en 5.9 jaar.
Belangrijke informatie
Herve Brailly
Algemeen directeur
€100.0k
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | 25.8yrs |
Eigendom CEO | 0.9% |
Management gemiddelde ambtstermijn | 4.6yrs |
Gemiddelde ambtstermijn bestuur | 5.9yrs |
Recente managementupdates
Recent updates
Risks To Shareholder Returns Are Elevated At These Prices For Innate Pharma S.A. (EPA:IPH)
Oct 24Benign Growth For Innate Pharma S.A. (EPA:IPH) Underpins Its Share Price
May 21Innate Pharma S.A. (EPA:IPH) Annual Results: Here's What Analysts Are Forecasting For This Year
Mar 24Is Innate Pharma (EPA:IPH) Using Debt In A Risky Way?
Dec 21Analysts' Revenue Estimates For Innate Pharma S.A. (EPA:IPH) Are Surging Higher
Sep 30Some Innate Pharma S.A. (EPA:IPH) Analysts Just Made A Major Cut To Next Year's Estimates
Sep 16Is Innate Pharma (EPA:IPH) Using Debt In A Risky Way?
Jun 09News Flash: Analysts Just Made A Massive Upgrade To Their Innate Pharma S.A. (EPA:IPH) Forecasts
Mar 30Rainbows and Unicorns: Innate Pharma S.A. (EPA:IPH) Analysts Just Became A Lot More Optimistic
Dec 18Does Innate Pharma (EPA:IPH) Have A Healthy Balance Sheet?
Sep 27Innate Pharma S.A. (EPA:IPH) Analysts Are Reducing Their Forecasts For This Year
Aug 04Industry Analysts Just Made A Dazzling Upgrade To Their Innate Pharma S.A. (EPA:IPH) Revenue Forecasts
May 12Industry Analysts Just Made A Captivating Upgrade To Their Innate Pharma S.A. (EPA:IPH) Revenue Forecasts
Apr 13Time To Worry? Analysts Just Downgraded Their Innate Pharma S.A. (EPA:IPH) Outlook
Mar 26Is Innate Pharma (EPA:IPH) Weighed On By Its Debt Load?
Nov 11CEO
Herve Brailly (63 yo)
25.8yrs
Tenure
€100,000
Compensatie
Dr. Herve Brailly, Ph.D. Co-Founded Innate Pharma S.A in 1999 and served as its Chairman of Supervisory Board since December 31, 2016 until January 1, 2024 and serves as its Interim CEO and Chairman of the...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Co-Founder | 25.8yrs | €100.00k | 0.91% € 1.3m | |
Executive VP | 9.4yrs | €599.92k | 0.24% € 330.1k | |
Founder | no data | geen gegevens | geen gegevens | |
Founder | 6.8yrs | geen gegevens | 0.26% € 357.4k | |
Founder | no data | geen gegevens | geen gegevens | |
Founder | no data | geen gegevens | geen gegevens | |
Founder | no data | geen gegevens | geen gegevens | |
Senior VP & CFO | 3.5yrs | geen gegevens | 0.014% € 19.3k | |
Executive VP | less than a year | geen gegevens | geen gegevens | |
Executive VP | less than a year | geen gegevens | geen gegevens | |
Vice President of Investor Relations & Communication | 1.8yrs | geen gegevens | 0.0039% € 5.4k | |
Vice President of Compliance & Operations | 5.8yrs | geen gegevens | 0.077% € 105.8k |
4.6yrs
Gemiddelde duur
57yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van IPH wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.6 jaar).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Strategic Advisory Board Member | 5.9yrs | geen gegevens | geen gegevens | |
Member of Supervisory Board | no data | geen gegevens | geen gegevens | |
Strategic Advisory Board | less than a year | geen gegevens | geen gegevens | |
Independent Member of Supervisory Board | 17.3yrs | €29.00k | 0.090% € 124.2k | |
Independent Supervisory Board Member | 2.4yrs | €45.00k | 0.0031% € 4.3k | |
Independent Member of Supervisory Board | 6.8yrs | €29.00k | 0.000060% € 82.6 | |
Independent Chairwoman of Supervisory Board | 15.3yrs | €42.00k | 0.031% € 42.7k | |
Independent Vice Chairperson of the Supervisory Board | 4.4yrs | €60.00k | 0.0012% € 1.7k | |
Chairman of Strategic Advisory Board | 5.9yrs | geen gegevens | geen gegevens | |
Independent Member of Supervisory Board | 9.5yrs | €48.00k | 0.00082% € 1.1k | |
Strategic Advisory Board | less than a year | geen gegevens | geen gegevens | |
Strategic Advisory Board Member | 5.9yrs | geen gegevens | geen gegevens |
5.9yrs
Gemiddelde duur
62.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van IPH wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.9 jaar).